Comparison studies of ultrasound-guided botulinum toxin injection and balloon catheter dilatation in the treatment of neurogenic cricopharyngeal muscle dysfunction

Abstract

BACKGROUND:

Cricopharyngeal muscle dysfunction (CPD) management has been challenging in clinical practice.

OBJECTIVE:

To compare the efficacy and safety of ultrasound-guided botulinum toxin injection and balloon catheter dilatation in treating CPD.

METHODS:

Forty patients with CPD were randomly divided into two groups, namely the botulinum toxin injection group (BTX group) and balloon dilatation group (BD group). Patients in the BTX group received a single ultrasound-guided injection of 50 units of botulinum toxin type A, while the BD group received dilatation therapy five times per week, consecutively for two weeks. Relative opening percentage of the upper esophageal sphincter (UES), the penetration-aspiration scale (PAS), and the Dysphagia Outcome Severity Scale (DOSS) were evaluated by a videofluoroscopic swallowing study (VFSS) at baseline, 1-month, and 3-months posttreatment. The Functional Oral Intake Scale (FOIS) and Standardized Swallowing Assessment (SSA) were also used to evaluate participants’ swallowing function at baseline and the 1-week, 2-week, 1-month, and 3-month follow-ups.

RESULTS:

A generalized estimating equation (GEE) model revealed the significant main effect for time in UES, PAS, DOSS, FOIS, and SSA compared to baseline (P <0.05), while no group-by-time interactions (except for the PAS assessment) or main effect for treatment was detected among the above multiple variances. No systematic complications or severe adverse effects were noted.

CONCLUSION:

Both ultrasound-guided botulinum toxin type A injections and balloon dilatation therapy have been proven as safe and effective treatments for CPD patients. Future clinical trials with longer follow-up periods and more participants are warranted.

Keywords

Neurogenic cricopharyngeal muscle dysfunction ultrasound-guided botulinum toxin injection balloon catheter dilatation therapy dysphagia

Get full access to this article

View all access options for this article.

References

Alberty,

, Oelerich,

, Ludwig,

, Hartmann,

, & Stoll,

(2000). Efficacy of botulinum toxin A for treatment of upper esophageal sphincter dysfunction. Laryngoscope, 110(7), 1151–1156. http://doi.org/10.1097/00005537-200007000-00016

Alfonsi,

, Restivo,

D. A.

, Cosentino,

, De Icco,

, Bertino,

, Schindler,

, Todisco,

, Fresia,

, Cortese,

, Prunetti,

, Ramusino,

M. C.

, Moglia,

, Sandrini,

, & Tassorelli,

(2017). Botulinum Toxin Is Effective in the Management of Neurogenic Dysphagia. Clinical-Electrophysiological Findings and Tips on Safety in Different Neurological Disorders. Frontiers in Pharmacology, 8, 80. http://doi.org/10.3389/fphar.2017.00080

Allen,

J. E.

(2016). Cricopharyngeal function or dysfunction: what’s the deal? Curr Opin Otolaryngol Head Neck Surg, 24(6), 494–499. http://doi.org/10.1097/MOO.0000000000000307

Ashman,

, Dale,

O. T.

, & Baldwin,

D. L.

(2016). Management of isolated cricopharyngeal dysfunction: systematic review. J Laryngol Otol, 130(7), 611–615. http://doi.org/10.1017/S0022215116007994

Atkinson,

S. I.

, & Rees,

(1997). Botulinum toxin for cricopharyngeal dysphagia: case reports of CT-guided injection. J Otolaryngol, 26(4), 273–276.

Blitzer,

, & Brin,

M. F.

(1997). Use of botulinum toxin for diagnosis and management of cricopharyngeal achalasia. Otolaryngol Head Neck Surg, 116(3), 328–330. http://doi.org/10.1016/s0194-5998(97)70267-5

Borders,

J. C.

, & Brates,

(2020). Use of the Penetration-Aspiration Scale in Dysphagia Research: A Systematic Review. Dysphagia, 35(4), 583–597. http://doi.org/10.1007/s00455-019-10064-3

Chiu,

M. J.

, Chang,

Y. C.

, & Hsiao,

T. Y.

(2004). Prolonged effect of botulinum toxin injection in the treatment of cricopharyngeal dysphagia: case report and literature review. Dysphagia, 19(1), 52–57. http://doi.org/10.1007/s00455-003-0029-3

Cock,

, Jones,

C. A.

, Hammer,

M. J.

, Omari,

T. I.

, & McCulloch,

T. M.

(2017). Modulation of Upper Esophageal Sphincter (UES) Relaxation and Opening During Volume Swallowing. Dysphagia, 32(2), 216–224. http://doi.org/10.1007/s00455-016-9744-4

10.

Crary,

M. A.

, Mann,

G. D.

, & Groher,

M. E.

(2005). Initial psychometric assessment of a functional oral intake scale for dysphagia in stroke patients. Arch Phys Med Rehabil, 86(8), 1516–1520. http://doi.org/10.1016/j.apmr.2004.11.049

11.

Dou,

, Zu,

, Wen,

, Wan,

, Jiang,

, & Hu,

(2012a). The effect of different catheter balloon dilatation modes on cricopharyngeal dysfunction in patients with dysphagia. Dysphagia, 27(4), 514–520. http://doi.org/10.1007/s00455-012-9402-4

12.

Huai,

, Hou,

, Guan,

, Zhang,

, Wang,

, Zhang,

, & Yue,

(2020). Botulinum Toxin A Injection Using Esophageal Balloon Radiography Combined with CT Guidance for the Treatment of Cricopharyngeal Dysphagia. Dysphagia, 35(4), 630–635. http://doi.org/10.1007/s00455-019-10070-5

13.

Kim,

D. Y.

, Park,

C. I.

, Ohn,

S. H.

, Moon,

J. Y.

, Chang,

W. H.

, & Park,

S. W.

(2006). Botulinum toxin type A for poststroke cricopharyngeal muscle dysfunction. Arch Phys Med Rehabil, 87(10), 1346–1351. http://doi.org/10.1016/j.apmr.2006.06.018

14.

Kocdor,

, Siegel,

E. R.

, & Tulunay-Ugur,

O. E.

(2016). Cricopharyngeal dysfunction: A systematic review comparing outcomes of dilatation, botulinum toxin injection, and myotomy. Laryngoscope, 126(1), 135–141. http://doi.org/10.1002/lary.25447

15.

Lan,

, Xu,

, Dou,

, Wan,

, Yu,

, & Lin,

(2013). Biomechanical changes in the pharynx and upper esophageal sphincter after modified balloon dilatation in brainstem stroke patients with dysphagia. Neurogastroenterol Motil, 25(12), e821–e829. http://doi.org/10.1111/nmo.12209

16.

Lee,

J. W.

, Randall,

D. R.

, Evangelista,

L. M.

, Kuhn,

M. A.

, & Belafsky,

P. C.

(2017). Subjective Assessment of Videofluoroscopic Swallow Studies. Otolaryngol Head Neck Surg, 156(5), 901–905. http://doi.org/10.1177/0194599817691276

17.

Leonard,

R. J.

, Kendall,

K. A.

, McKenzie,

, Goncalves,

M. I.

, & Walker,

(2000). Structural displacements in normal swallowing: a videofluoroscopic study. Dysphagia, 15(3), 146–152. http://doi.org/10.1007/s004550010017

18.

Lierse,

(1992). The physiology and pathology of the esophagus. Eur J Pediatr Surg, 2(6), 323–326. http://doi.org/10.1055/s-2008-1063470

19.

Martin-Harris,

, Brodsky,

M. B.

, Michel,

, Castell,

D. O.

, Schleicher,

, Sandidge,

, Maxwell,

, & Blair,

(2008). MBS measurement tool for swallow impairment–MBSImp: establishing a standard. Dysphagia, 23(4), 392–405. http://doi.org/10.1007/s00455-008-9185-9

20.

O’Neil,

K. H.

, Purdy,

, Falk,

, & Gallo,

(1999). The Dysphagia Outcome and Severity Scale. Dysphagia, 14(3), 139–145. http://doi.org/10.1007/PL00009595

21.

Orsini,

, Leite,

M. A.

, Chung,

T. M.

, Bocca,

, de Souza,

J. A.

, de Souza,

O. G.

, Moreira,

R. P.

, Bastos,

V. H.

, Teixeira,

, Oliveira,

A. B.

, Moraes,

B. S.

, Matta,

A. P.

, & Jacinto,

L. J.

(2015). Botulinum Neurotoxin Type A in Neurology: Update. Neurol Int, 7(2), 5886. http://doi.org/10.4081/ni.2015.5886

22.

Panebianco,

, Marchese-Ragona,

, Masiero,

, & Restivo,

D. A.

(2020). Dysphagia in neurological diseases: a literature review. Neurol Sci, 41(11), 3067–3073. http://doi.org/10.1007/s10072-020-04495-2

23.

Park,

, Oh,

, & Ryu,

J. S.

(2016). Findings of Abnormal Videofluoroscopic Swallowing Study Identified by High-Resolution Manometry Parameters. Arch Phys Med Rehabil, 97(3), 421–428. http://doi.org/10.1016/j.apmr.2015.10.084

24.

Park,

Y. H.

, Bang,

H. L.

, Han,

H. R.

, & Chang,

H. K.

(2015). Dysphagia screening measures for use in nursing homes: a systematic review. Journal of Korean Academy of Nursing, 45(1), 1–13. http://doi.org/10.4040/jkan.2015.45.1.1

25.

Regan,

, Murphy,

, Chiang,

, McMahon,

B. P.

, Coughlan,

, & Walshe,

(2014). Botulinum toxin for upper oesophageal sphincter dysfunction in neurological swallowing disorders. Cochrane Database Syst Rev (5), D9968. http://doi.org/10.1002/14651858.CD009968.pub2

26.

Rosenbek,

J. C.

, Robbins,

J. A.

, Roecker,

E. B.

, Coyle,

J. L.

, & Wood,

J. L.

(1996). A penetration-aspiration scale. Dysphagia, 11(2), 93–98. http://doi.org/10.1007/BF00417897

27.

Solt,

, Bajor,

, Moizs,

, Grexa,

, & Horvath,

P. O.

(2001). Primary cricopharyngeal dysfunction: treatment with balloon catheter dilatation. Gastrointest Endosc, 54(6), 767–771. http://doi.org/10.1067/mge.2001.118442

28.

Terre,

, Valles,

, Panades,

, & Mearin,

(2008). Long-lasting effect of a single botulinum toxin injection in the treatment of oropharyngeal dysphagia secondary to upper esophageal sphincter dysfunction: a pilot study. Scand J Gastroenterol, 43(11), 1296–1303. http://doi.org/10.1080/00365520802245403

29.

Wang,

Y. C.

, Shyu,

S. G.

, Wu,

C. H.

, & Wang,

T. G.

(2018). Ultrasound-Guided Injection of Botulinum Toxin for Cricopharyngeal Dysphagia. Am J Phys Med Rehabil, 97(10), 97(10), e102–e103. http://doi.org/10.1097/PHM.0000000000000959

30.

Wei,

, Yu,

, Dai,

, Xie,

, Wan,

, Wang,

, & Dou,

(2017). Change in Excitability of Cortical Projection After Modified Catheter Balloon Dilatation Therapy in Brainstem Stroke Patients with Dysphagia: A Prospective Controlled Study. Dysphagia, 32(5), 645–656. http://doi.org/10.1007/s00455-017-9810-6

31.

Yang,

, Yi,

, Han,

, & Kim,

H. J.

(2018). Characteristics of Cricopharyngeal Dysphagia After Ischemic Stroke. Ann Rehabil Med, 42(2), 204–212. http://doi.org/10.5535/arm.2018.42.2.204

32.

Zhou,

, Zhu,

, & Zhang,

(2017). Validation of the Chinese Version of the Functional Oral Intake Scale (FOIS) Score in the Assessment of Acute Stroke Patients with Dysphagia. Stud Health Technol Inform, 245, 1195–1199.